Tandem Diabetes Care, Inc.TNDMNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+6.4%
5Y CAGR+17.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+6.4%/yr
vs +39.3%/yr prior
5Y CAGR
+17.8%/yr
Recent deceleration
Acceleration
-32.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $608.97M | +3.4% |
| 2024 | $588.70M | -2.0% |
| 2023 | $600.92M | +18.8% |
| 2022 | $505.83M | +43.1% |
| 2021 | $353.56M | +31.7% |
| 2020 | $268.48M | +27.3% |
| 2019 | $210.93M | +56.9% |
| 2018 | $134.45M | +25.6% |
| 2017 | $107.04M | +5.3% |
| 2016 | $101.64M | - |